Acetazolamide 250 mg, 100 Tablets

HYPP Medications for Horses

Product Description:

Used primarily to treat hyperkalemic periodic paralysis (HYPP), a genetic disease of the neuromuscular system. Also used to decrease intraocular pressure in the treatment of glaucoma in animals.

Drug Class:

Diuretic

Adverse Effects:

Acetazolamide can potentially produce hypkalemia in some patients.

Contraindications, Precautions, and Drug Interactions:

Do not use in patients with acidemia. Use with caution in any animals sensitive to sulfonamides.

Small Animal Dosage Information:

Dogs and Cats: For glaucoma: 5-10 mg/kg, Every 8-12 hours, by mouth. For other dosage information see your veterinarian.

*When used to treat glaucoma, monitor patient's ocular pressure.

Hyperkalemic Periodic Paralysis Disease (HYPP) is a muscular disease that affects both horses and humans. It is caused by a hereditary genetic defect that disrupts a protein called a sodium ion channel, a tiny gateway in the membrane of muscle cells. The genetic defect disrupts the channel's normal opening and closing, such that uncontrolled sodium influxes occur. These influxes in turn change the voltage current of muscle cells, causing uncontrolled muscle twitching or profound muscle weakness. High levels of potassium in the blood usually are present when the disruptions in the ion channel occur.

What Are Effects of HYPP?

Horses with HYPP can experience unpredictable attacks of paralysis which, in severe cases, can lead to collapse and sudden death. The cause of death usually is cardiac arrest and /or respiratory failure. The disease is characterized by intermittent episodes of muscle tremors manifested by generalized or localized shaking, trembling and weakness. Occasionally, episodes are accompanied by respiratory noises resulting from paralysis of the muscles of the upper airway (larynx and pharynx). In cases of mild attacks, muscle tremors may be so subtle as to be detectable only by an experienced clinician performing EMG testing.

Can Symptoms of HYPP Vary in Severity?

Clinical signs of HYPP do vary widely among different horses. Homozygous horses are affected more severely than heterozygous horses. Under ideal management practices, the defective gene does not appear to have adverse effects, but stress and/or increased potassium in the serum can trigger clinical signs of muscle dysfunction. Why some horses manifest severe signs of the disease and other exhibit little or no signs is unknown but currently under investigation. Unfortunately, a horse carrying the defective gene but showing minimal signs has the same chance of passing the gene to future generations as does the affected horse with severe signs.

What is the Origin of the Genetic Defect Causing HYPP?

The original genetic defect causing HYPP was a natural mutation that occurred as part of the evolutionary process. The majority of such mutations, which are constantly occurring, are not compatible with survival. However, the genetic mutation causing HYPP produced a functional, yet altered, sodium ion channel. This gene mutation is not a product of inbreeding. The gene mutation causing HYPP inadvertently became widespread when breeders sought to produce horses with heavy musculature.

Is HYPP Limited To A Particular Bloodline of Horses?

HYPP is associated with horses of heavy musculature, but this does not mean that all horses with well developed musculature are afflicted with the disease. The mutant gene causing HYPP presently has been identified in the descendents of the horse "Impressive." Research has not yet been performed on other bloodlines to ascertain whether the same or similar genetic mutation existing in other bloodlines also may cause HYPP. Since "Impressive" descendants are so numerous, the genetic mutation in the bloodline is widespread. Theoretically, it is possible that other mutations causing HYPP in different bloodlines may be more difficult to identify because they are not so widespread.

HYPP is unique in that it is the first equine disease in which breeding and molecular genetics have yielded a specific genetic mutation identifiable with a named bloodline. It only is a matter of time before other heritable conditions in various bloodlines likewise can be identified.

How is HYPP Inherited In Horses?

Based upon breeding trials conducted at the Equine Research Laboratory at the University of California at Davis, it was determined that HYPP is inherited as an autosomal dominant trait, which means it can occur in both males and females. The trait is inherited from generation to generation with equal frequency; it does not get "diluted" out. Breeding an affected heterozygous horse (N/H) to a normal horse (N/N) will result in approximately 50% normal offspring, while 50% will carry the defective gene (N/H). Breeding an affected homozygote (H/H) will result in all offspring carrying the gene mutation, regardless of the status of the other parent.

Normal (N/N) offspring safely can be bred, without fear of HYPP being inherited. Selective breeding to normal (N/N) horses could entirely eliminate HYPP disease. As HYPP is inherited as a dominant condition, it can and is being spread to other breeds. It is to everyone's benefit to take the necessary steps to selectively breed HYPP out of existence before it becomes so widespread that this is impossible.

Can Horses be Tested for HYPP?

A DNA test now has been developed and presently is available at UC Davis to identify horses carrying the defective gene causing HYPP. This blood test detects the presence or absence of the specific genetic mutation which has been found in the extended pedigree of "Impressive" descendants. From a whole blood sample a part of the gene coding for the horse muscle sodium channel is amplified, cut (using enzymes which cut specific DNA sequences), separated by electrophoresis, stained and read. Based on the number of DNA fragments observed, it can be determined whether the horse does not carry this specific mutation (a normal horse), or whether it carries one or two copies of this abnormal gene mutation (heterozygous or homozygous for HYPP, respectively).

How Accurate Is the DNA Blood Test for HYPP?

The test is accurate and reliable based upon research studies. The presence of the genetic mutation has been found to be associated with the disease. In a prior publication (Nature Genetics 1992, Volume 2, p.144-147), we reported upon our testing of 51 related horses which were diagnosed with HYPP based upon documented episodes of muscle fasciculations or paralysis not induced by exercise. All 51 horses were positive (for the sodium channel mutation) using this test. An equal number of related horses which were determined to be normal (based upon potassium challenge and /or free clinical signs of muscle disease) were negative for the gene mutation. We also tested 130 horses from 5 different breeds to determine if the mutation could be found with any frequency in the general horse population. The only horses to date which have shown the mutation have been descendants of "Impressive" but, theoretically, other mutations may exist for which we now have the tools to start looking. The test has proven to be reliably repeatable, as we routinely re-run samples and we have not encountered any discrepancies in results following retesting.

Are False Negative or False Positive HYPP Test Results Possible?

"False" Negatives: We have encountered a rare few horses which show various clinical signs of muscle disease but are negative for the specific gene mutation in the sodium channel. All are privately owned horses which we have been unable to study thoroughly. None of these horses has demonstrated increased blood potassium concentration in association with abnormal clinical signs. Two horses had markedly high muscle enzyme measurements, and one horse had marked muscle damage evident on muscle biopsy. We feel at this time that these horses probably have another muscle disease and not HYPP. We are sequencing the sodium channel for such horses to determine if a second mutation actually exists.

"False" Positives: We have not identified any horses which carry the gene mutation and do not have the disease. Of 142 samples we have received accompanied by clinical information, approximately 30% of the positive horses have not shown abnormal clinical signs (according to their owners). All have been young horses (aged 4 or less). None of these horses has tested negative by other means (such as response to potassium challenge or electromyography).

No diagnostic test is 100% accurate. Errors feasibly could occur by several means. If the test result conflicts with clinical data, then it is possible that the tube of blood was mislabeled or mishandled in the laboratory. Retesting should be performed. However, based on the results to date, we can say with confidence that the presence of the mutation is the cause of HYPP, and the test is accurate and reliable. The test is extremely specific, and is accurate for the gene sequence substitution which has been shown to cause HYPP in descendants of "Impressive". Theoretically, it is feasible that a different horse bloodline could have a mutation in another portion of the sodium channel which might produce a similar form of muscle disease and not be detected by this test. If this occurs, careful documentation of the clinical signs and corresponding laboratory results (including serum potassium and muscle-derived enzyme concentrations) should be used to confirm the diagnosis.

Which Horses Should Be Tested for HYPP?

As noted above, the DNA blood test for HYPP identifies the specific genetic mutation which we now know exists in descendants of "Impressive". We presently do not know whether different genetic mutations in other bloodlines also cause HYPP, and the DNA blood test will not identify other such mutations. Further scientific research is required as to other bloodlines. We presently recommend that all descendants of "Impressive" be tested for diagnostic, treatment and breeding purposes.

Are HYPP Test Results Confidential?

Test results are treated as confidential at our facility. We notify the individual who requested the test by mail or fax of the results.

Do Horses Outgrow HYPP?

No. An affected horse is affected for life, but symptomatology does seem to decrease with age. The disease also appears to be associated with periods of stress, transport, concurrent diseases, initiation of training or intensive training, and dietary changes. It is possible that older horses do not experience the same degree of stress as young horses (i.e., they are not subject to the rigorous show schedules of younger horses and their owners have discovered the best diet and management routines for these older horses).

Can Effective Treatment Be Rendered to HYPP-Afflicted Horses?

HYPP in horses can be managed, and incidents of mortality significantly reduced, by proper diet and the administration of medication. While further studies on the mortality rate of HYPP are required, it is important to put HYPP into perspective relative to the many other conditions afflicting horses. Horses afflicted with HYPP, if properly managed, can lead productive, useful lives, and bring their owners many hours of pleasure.

The first step towards effectively managing HYPP is to have the disease properly diagnosed. It can be confused with other conditions, such as "tying up". It is essential that you consult with your veterinarian if you wish to ascertain whether your horse has HYPP. We recommend the DNA blood test as the most effective and reliable means of diagnosing HYPP.

What Emergency Treatment is Recommend For Acute Attacks of HYPP?

For a mild attack (when the horse is not down but has muscle tremors), one or more of the following emergency treatments are recommended.

Exercise the horse, either by walking or longing. Exercise stimulates adrenalin which helps replace potassium inside cells. However, use caution, as the horse could stumble and fall while sustaining muscle tremors.

Feed grain (oats, dry corn-oats-barley or light Karo syrup for glucose supplement). Feeding carbohydrates supplies glucose which stimulates the release of insulin and promotes potassium uptake by cells.

Administer acetazolamide orally (3 mg/kg). This is usually 6 to 8 tablets if the tablets are 250 mg each. Acetazolamide increases potassium excretion from the kidney and also affects glucose metabolism.

For severe attacks, immediate veterinary attention is necessary. If the horse is down and unable to stand, have your veterinarian:

Place intravenous (IV) catheter and administer 23% calcium gluconate (150 cc in 1-2 liters of 5% glucose/500 kg horse). The majority of horses respond immediately to this and stand up.

If no response, follow with 1 L 5% sodium bicarbonate IV (dose is 1 meq/kg).

Still no response, give 3 L 5% dextrose IV, and monitor potassium levels in blood.

All of these treatments help stabilize the muscle membranes and lower blood potassium. Your veterinarian should draw a blood sample prior to initiation of treatment in order to analyze the blood potassium and muscle enzyme concentrations. This is required to confirm that the horse was suffering an attack of HYPP and not something else (i.e., colic).

What Management Practices Will Help control HYPP?

The following management practices will greatly assist in the control of HYPP:

Establish regular feeding and exercise schedule. Avoid fasting and water deprivation. Horses do better if allowed access to a paddock or pasture rather than strict stall confinement. Daily or nightly turnout is helpful.

Adult horses do very well on grass or oat hay alone or pasture. If it is necessary to use alfalfa to balance the ration for growing horses, then mix alfalfa with grass hay or oat hay and grain (oats are best) to decrease potassium content of diet. Feed equal amounts of hay and grain two or three times daily. Avoid rapid changes in diet. Provide access to a white salt block or feed loose salt. Administer acetazolamide (Diamox), a diuretic, (2 mg/kg orally twice a day). Many halter-horse owners continue to feed alfalfa hay as the only roughage but maintain their horses on this drug for all or most of their lives. Please note that this drug is a forbidden substance under AQHA and AHSA regulations.

Inform your veterinarian of HYPP condition prior to any general anesthesia, which may precipitate an episode of paralysis. Maintain acetazolamide therapy before and after surgery or anesthesia.

Use common sense while hauling. Be sure to stop and water horse frequently (every 2 hours). Acetazolamide treatment is helpful to prevent problems.